CRT 2026

Panel Discussion | PPMI New Definitions in Clinical Trials

Moderator(s)

• 

  Mitchell Krucoff, MD, FACC, FAHA, FSCAI

  Professor Medicine/Cardiology
  Duke University Medical Center/Duke Clinical Research Institute
  Durham, North Carolina, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed / Johnson & Johnson: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Getinge: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Nipro Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Shockwave/Johnson&Johnson: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Terumo Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Panel Discussant(s)

• 

  Rafael Cavalcante, MD, PhD

  Vice President, Global Clinical
  Boston Scientific
  Newton, Massachusetts, United States

  Disclosure(s): Boston Scientific: Employee (Ongoing)
• 

  Hector M. Garcia-Garcia, MD, PhD

  Director of Invasive Imaging Core Laboratory
  MedStar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing)
• 

  William Herzog, MD, FACC, FSCAI

  Physician
  FDA

  Disclosure(s): No financial relationships to disclose
• 

  Gregg W. Stone, MD, FACC, MSCAI

  Physician
  Mount Sinai
  New York, New York, United States

  Disclosure(s): Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)
• 

  Ernest Spitzer, MD

  Chief Executive Officer
  Cardialysis B.V.
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biosensors Europe: Grant/Research Support (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing); Edward Lifesciences: Grant/Research Support (Ongoing); Medtronic Inc: Grant/Research Support (Ongoing); Novo Nordisk A/S: Grant/Research Support (Ongoing); Philips Medical: Grant/Research Support (Ongoing); Pie Medical Imaging: Grant/Research Support (Ongoing); Siemens Healthineers AG: Grant/Research Support (Ongoing)
• 

  Robert W. Yeh, MD, MSc

  Professor of Medicine
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)